Drugmakers spent freely in 2022 to protect revenue

Pfizer, Amgen, Bristol-Myers Squibb bought makers of proven drugs ahead of rising competition.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...